P1327: RUXOLITINIB COMBINED WITH GLUCOCORTICOID IN THE FIRST-LINE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN CHILDREN: A SINGLE CENTER RETROSPECTIVE STUDY

Podobne zapisy

• The impact of COVID-19 in children post hematopoietic stem cell transplantation: Experience from a pediatric transplant unit in India
  od: Rumesh Chandar, i wsp.
  Wydane: (2022-06-01)
• Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis
  od: Sara Villar, i wsp.
  Wydane: (2025-04-01)
• Chemotherapy for childhood acute myeloid leukemia and associated infections over two decades in India: Timeline and impact on outcome
  od: Ramya Uppuluri, i wsp.
  Wydane: (2020-01-01)
• A Systematic Review of Treatments for Cutaneous Chronic Graft-versus-Host Disease
  od: M. Zhou, i wsp.
  Wydane: (2026-02-01)
• Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation
  od: Nurşah Eker, i wsp.
  Wydane: (2022-06-01)